Atomera (ATOM) Q2 2024: Operating Expenses Down $730K as Licensing Pipeline Expands

Atomera’s second quarter revealed disciplined cost control alongside broadened engagement across power, RF SOI, memory, and advanced node customers. Key licensing and production milestones remain pending, but the company’s pipeline and segmental breadth signal a potential inflection if deal closures accelerate. Investor focus now shifts to the pace of conversion from technical progress to recurring revenue.

Summary

  • Pipeline Expansion: Customer proposals and segment activity broadened, but license conversion remains the gating factor.
  • Cost Discipline: Reduced R&D and sales expense preserved cash, extending runway even as revenue remains nascent.
  • Deal Closure Watch: Execution on STMicro and JDA2 conversion will determine revenue base and validate commercial model.

Business Overview

Atomera develops and licenses MST (Mears Silicon Technology), a semiconductor materials technology that enhances transistor performance for foundries, integrated device manufacturers, and fabless chip companies. The company’s revenue model is built on engineering services, software licenses (MSTCAD), and production royalties. Major customer segments include power semiconductors, RF SOI (radio frequency silicon-on-insulator), memory (DRAM), and advanced logic nodes. Atomera’s growth potential hinges on the adoption of its technology into customers’ high-volume manufacturing, which triggers recurring royalty streams.

Performance Analysis

Atomera’s Q2 2024 results reflected modest revenue progress, with $72,000 recognized, mostly from engineering services and MSTCAD software licensing. This is a sequential improvement, but still immaterial relative to the company’s addressable market and cost base. The net loss narrowed to $4.4 million GAAP, primarily due to a $730,000 reduction in operating expenses, as R&D spend declined following the closure of the TSI Semiconductor foundry and lower sales and marketing headcount. Cash burn was $3.2 million, with the quarter-end cash balance at $18.3 million, bolstered by $2.4 million in ATM equity proceeds.

Revenue remains highly concentrated in early-phase activities, with the next major milestone tied to STMicro’s production qualification. The company continues to operate below its planned expense run rate, providing additional flexibility as it works to convert its pipeline to commercial agreements.

  • R&D Spend Reset: R&D expense fell $603,000 YoY as Atomera pivots to a multi-partner foundry model post-TSI closure.
  • Sales and Marketing Streamlined: Expense fell $186,000 YoY, with targeted hiring intended to accelerate deal closure.
  • Cash Preservation: ATM equity sales and reduced OPEX extend the company’s operational runway.

Despite the expanding pipeline and deepening customer engagement, recurring revenue and license conversion remain the missing link for the business model to scale.

Executive Commentary

"We are working very closely [with STMicro] together. And I think progress is going very, very well."

Scott Bebo, President and CEO

"For the full year, we now expect our OPEX to come in lower than my previous guidance."

Frank Lorenzio, CFO

Strategic Positioning

1. Power Semiconductor Segment as Anchor

STMicroelectronics, power chip partner, remains Atomera’s highest priority and the most advanced in the pipeline. The company’s weekly collaboration with STMicro’s Smart Power Division aims to drive MST adoption into high-volume production, setting up a foundational royalty stream. The segment’s scale ($1.9 billion in ST’s Q2 revenue) underscores the potential magnitude if commercialization is achieved.

2. RF SOI and Substrate Innovation

Atomera’s collaboration with Soitec, leading RFSOI substrate supplier, addresses a critical bottleneck for RF customers by enabling MST integration on production-quality thin wafers. This directly responds to customer requests and is expected to lower adoption friction and accelerate time-to-market for RF SOI applications, especially in 5G and high-frequency domains.

3. Memory and Advanced Node Engagements

In memory, DRAM manufacturers, highly cost-sensitive customers, are engaged at various adoption stages. Atomera’s value proposition centers on die size reduction and margin improvement, with DRAM’s rapid node cycles (new nodes every 18 months) potentially enabling faster design-in and revenue ramp than more complex logic or RF segments. Meanwhile, gate-all-around (GAA) advanced node work is underway with major players, though timelines remain long and variable.

4. GaN Technology as Emerging Adjacent

Gallium nitride (GaN) R&D, though early, is attracting outsized customer interest. Atomera is already in discussions with four potential partners, targeting the rapidly growing power GaN market (41% growth in 2023). Initial development wafer revenue could materialize before year-end, serving as a signal of market validation.

5. Commercial Execution Reset

Recognizing a gap in deal closure, Atomera has recruited a new head of business development and marketing with deep industry relationships and technical expertise. The company is also adding engineering and sales capacity, aiming to convert its record proposal pipeline into signed licenses and production agreements.

Key Considerations

Atomera’s quarter was defined by operational discipline and broad technical progress, but the commercial inflection remains dependent on closing key licensing and production agreements. The company’s addressable market spans multiple high-growth semiconductor segments, but realization of this potential is contingent on overcoming adoption cycles and customer qualification timelines.

Key Considerations:

  • STMicro Progress: Weekly technical engagement is ongoing, but the production schedule is controlled by ST and timing remains opaque.
  • RF SOI Adoption Catalyst: The Soitec substrate partnership removes a key technical barrier and could accelerate RF segment licensing.
  • DRAM and GAA Timelines: Memory may offer a quicker path to production revenue than advanced logic nodes, given DRAM’s rapid node transitions.
  • GaN Market Entry: Early customer traction in GaN could provide incremental revenue and diversify Atomera’s market footprint.
  • Execution Risk: The company’s candid admission of past sales bottlenecks and new leadership hires reflect a pivot toward commercial urgency.

Risks

Atomera’s principal risk is execution on license conversion and production ramp, as technical validation alone has not yet yielded recurring revenue. Customer adoption cycles, especially with large semiconductor companies, are lengthy and bureaucratic. The company’s reliance on a few large partners (notably STMicro) concentrates risk, and cash burn remains material relative to current revenue. Macro semiconductor demand, competitive materials innovation, and the pace of CHIPS Act funding could all influence adoption timelines and revenue visibility.

Forward Outlook

For Q3 2024, Atomera guided to:

  • Approximately $20,000 in revenue, solely from MSTCAD license fees

For full-year 2024, management lowered non-GAAP operating expense guidance to:

  • $16.25 million to $16.75 million

Management highlighted several factors that shape the outlook:

  • STMicro’s production qualification remains the next major revenue trigger, but timing is outside Atomera’s control
  • Incremental hiring in sales and engineering aims to accelerate deal closure and support customer conversions

Takeaways

Atomera’s Q2 demonstrated technical momentum and cost discipline, but the key investor watchpoint is the pace of license-to-production conversion.

  • Execution on STMicro and JDA2 will define near-term revenue base: Weekly collaboration and positive test data are encouraging, but investors need to see signed deals and production ramp.
  • Segmental breadth provides optionality: RF SOI, DRAM, GaN, and GAA node engagements broaden the addressable market and reduce reliance on a single vertical.
  • Commercial urgency is rising: New business development leadership and targeted hiring are intended to address the sales cycle bottleneck and accelerate pipeline conversion.

Conclusion

Atomera is positioned at the intersection of technical progress and commercial inflection, with disciplined cost management buying time for deal conversion. Investor focus remains squarely on the translation of pipeline activity into recurring revenue, with STMicro and RF SOI as the most immediate catalysts to watch.

Industry Read-Through

Atomera’s update underscores the protracted and technical nature of materials adoption in the semiconductor supply chain, where even strong technical validation requires persistent engagement to achieve licensing and production ramp. RF SOI and power segments are seeing innovation bottlenecks that create opportunity for differentiated materials providers, but customer qualification hurdles remain high. The growing interest in GaN and the CHIPS Act’s shift toward materials innovation are signals for other enabling technology firms to align with downstream customer needs and government priorities. Execution on commercial milestones, not just technical progress, will increasingly separate winners from the field.